Business
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform SEATTLE, March 02, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice President of Sales. Ms. Faust joins Nautilus following the public debut of the Nautilus Voyager™ Platform, designed to deliver
About this update from Waters Corporation
[{"type":"image","alt":"Nautilus Biotechnology Inc.","displaySize":"","headline":null,"caption":"Nautilus Biotechnology Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gZG4ft0bTsyv782wsqtQmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864","width":300,"height":95}},"lazy":false},{"type":"text","content":"Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform","length":172,"tagName":"p"},{"type":"image","alt":"Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform","displaySize":"","headline":null,"caption":"Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform","className":"","disableSlideshowImg":false,"size":{"original":{"width":221,"height":221,"url":"https://media.zenfs.com/en/globenewswire.com/7e3746cc3e77eac74d1e50bae3995fbb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZVuLeraI453lwH6gZ_wxug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7e3746cc3e77eac74d1e50bae3995fbb","width":221,"height":221}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"SEATTLE, March 02, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice President of Sales. Ms. Faust joins Nautilus following the public debut of the Nautilus Voyager™ Platform, designed to deliver and scale Iterative Mapping, a method that enables single-molecule analysis of proteins and proteoforms across the proteome.","length":451,"tagName":"p"},{"type":"text","content":"Ms. Faust brings nearly two decades of commercial leadership experience in life sciences, with a focus on advancing adoption of emerging proteomics technologies across pharmaceutical, biotechnology, academic, clini...